Biofrontera AG - ADR
BFRA - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$75.72M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $75.72 Million |
|---|---|
| Enterprise Value | $78.56 Million |
| Earnings per Share | $-0.47 |
| Beta | 1.55 |
| Outstanding Shares | 28,358,692 |
Return
| Return on Equity | -106.87% |
|---|---|
| Return on Assets | -26.45% |
| Return on Invested Capital | -50.93% |
Valuation & Multiples
| P/E Ratio | -1.45 |
|---|---|
| PEG | 1.64 |
| Price to Sales | 2.67 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.7 |
| Enterprise Value to EBIT | -11.41 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 1.26 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Biofrontera Inc
82 employees
CEO: Hermann Lübbert
Biofrontera AG, a biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally. The company off...